$525 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GILD | Buy | GILEAD SCIENCES INC | $48,830,000 | +62.0% | 838,140 | +75.7% | 9.29% | +35.4% |
MRK | Buy | MERCK & CO INC | $47,298,000 | +45.0% | 578,211 | +47.0% | 9.00% | +21.2% |
INCY | Buy | INCYTE CORP | $30,585,000 | +19.6% | 351,629 | +23.4% | 5.82% | +0.0% |
BDX | New | BECTON DICKINSON & CO | $30,488,000 | – | 121,845 | +100.0% | 5.80% | – |
MDT | Sell | MEDTRONIC PLC | $27,823,000 | -16.4% | 237,523 | -25.8% | 5.30% | -30.1% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $24,816,000 | +17.0% | 690,282 | +24.4% | 4.72% | -2.2% |
ALXN | Sell | ALEXION PHARMACEUTICALS INC | $23,096,000 | -6.2% | 147,827 | -31.3% | 4.40% | -21.5% |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $22,414,000 | -31.3% | 361,343 | -33.2% | 4.26% | -42.6% |
PFE | New | PFIZER INC | $21,838,000 | – | 593,250 | +100.0% | 4.16% | – |
PKI | Sell | PERKINELMER INC | $20,654,000 | -18.8% | 143,931 | -29.0% | 3.93% | -32.1% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $18,149,000 | +61.8% | 320,992 | +35.8% | 3.45% | +35.3% |
BRKR | Sell | BRUKER CORP | $17,726,000 | +15.2% | 327,477 | -15.4% | 3.37% | -3.7% |
ABT | Sell | ABBOTT LABS | $16,713,000 | -9.8% | 152,640 | -10.3% | 3.18% | -24.6% |
CVS | Sell | CVS HEALTH CORP | $16,106,000 | +9.5% | 235,818 | -6.3% | 3.06% | -8.4% |
BIIB | Sell | BIOGEN INC | $16,059,000 | -15.9% | 65,585 | -2.6% | 3.06% | -29.7% |
CAH | Buy | CARDINAL HEALTH INC | $15,578,000 | +16.3% | 290,850 | +2.0% | 2.96% | -2.8% |
ANTM | Sell | ANTHEM INC | $15,207,000 | -16.5% | 47,360 | -30.1% | 2.89% | -30.2% |
LH | Buy | LABORATORY CORP AMER HLDGS | $14,669,000 | +29.3% | 72,064 | +19.6% | 2.79% | +8.1% |
NUVA | Sell | NUVASIVE INC | $14,384,000 | +2.3% | 255,360 | -11.8% | 2.74% | -14.5% |
LIVN | Buy | LIVANOVA PLC | $13,323,000 | +105.6% | 201,230 | +40.4% | 2.54% | +71.9% |
BIO | Sell | BIO RAD LABS INCcl a | $12,485,000 | -4.8% | 21,417 | -15.9% | 2.38% | -20.4% |
CNC | New | CENTENE CORP DEL | $11,647,000 | – | 194,012 | +100.0% | 2.22% | – |
ELAN | Buy | ELANCO ANIMAL HEALTH INC | $11,295,000 | +102.1% | 368,291 | +84.0% | 2.15% | +68.9% |
HCA | Sell | HCA HEALTHCARE INC | $10,560,000 | +28.4% | 64,210 | -2.6% | 2.01% | +7.4% |
PRGO | Sell | PERRIGO CO PLC | $7,509,000 | -24.5% | 167,922 | -22.5% | 1.43% | -36.9% |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $5,595,000 | +70.7% | 1,598,649 | +17.1% | 1.06% | +42.8% |
JNJ | Sell | JOHNSON & JOHNSON | $5,508,000 | -35.2% | 35,000 | -38.7% | 1.05% | -45.8% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $3,849,000 | +35.6% | 29,615 | +51.9% | 0.73% | +13.3% |
NVAX | New | NOVAVAX INC | $1,282,000 | – | 11,500 | +100.0% | 0.24% | – |
CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -156,969 | -100.0% | -0.21% | – |
CERN | Exit | CERNER CORP | $0 | – | -26,122 | -100.0% | -0.43% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -169,734 | -100.0% | -3.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.